Individual investors Have A Lot Riding On Lithium Chile Inc. (CVE:LITH)

In This Article:

Key Insights

  • Lithium Chile's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public

  • A total of 10 investors have a majority stake in the company with 49% ownership

  • Insiders own 12% of Lithium Chile

To get a sense of who is truly in control of Lithium Chile Inc. (CVE:LITH), it is important to understand the ownership structure of the business. With 51% stake, individual investors possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).

In the chart below, we zoom in on the different ownership groups of Lithium Chile.

View our latest analysis for Lithium Chile

ownership-breakdown
TSXV:LITH Ownership Breakdown July 2nd 2024

What Does The Lack Of Institutional Ownership Tell Us About Lithium Chile?

Institutional investors often avoid companies that are too small, too illiquid or too risky for their tastes. But it's unusual to see larger companies without any institutional investors.

There could be various reasons why no institutions own shares in a company. Typically, small, newly listed companies don't attract much attention from fund managers, because it would not be possible for large fund managers to build a meaningful position in the company. It is also possible that fund managers don't own the stock because they aren't convinced it will perform well. Institutional investors may not find the historic growth of the business impressive, or there might be other factors at play. You can see the past revenue performance of Lithium Chile, for yourself, below.

earnings-and-revenue-growth
TSXV:LITH Earnings and Revenue Growth July 2nd 2024

Lithium Chile is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is Chengxin Lithium Group Co., Ltd. with 18% of shares outstanding. Gator Capital Ltd. is the second largest shareholder owning 18% of common stock, and Albert Kroontje holds about 4.7% of the company stock. Albert Kroontje, who is the third-largest shareholder, also happens to hold the title of Chairman of the Board. In addition, we found that Steven Cochrane, the CEO has 1.6% of the shares allocated to their name.

Our studies suggest that the top 10 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.